OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001100397

Ayala Pharmaceuticals, Inc.

Ayala Pharmaceuticals, Inc. (CIK 0001100397, EIN 84-1521955) reported revenue of $13,000 for FY2023 (2023-01-01 to 2023-12-31) and net income of -$48.07 million (-$48,072,000) for FY2023 (2023-01-01 to 2023-12-31), as filed in its 10-K filed 2024-04-16 (accession 0001493152-24-014822).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends December 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001100397
EIN84-1521955
SIC industry code2834 Pharmaceutical Preparations
State or country of incorporationDE
Fiscal year endDecember 31
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
Olympus entity IDorg_2h8mk5yk6k4x2mqr9m1tmxyhd3
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$13,000FY20232023-01-01 to 2023-12-3110-K2024-04-160001493152-24-014822Revenues
Net income-$48,072,000FY20232023-01-01 to 2023-12-3110-K2024-04-160001493152-24-014822NetIncomeLoss
Total assets$16,579,000FY2023as of 2023-12-3110-K2024-04-160001493152-24-014822Assets
Total liabilities$2,303,000FY2022as of 2022-10-3110-K2023-02-100001493152-23-004167Liabilities
Stockholders' equity-$24,417,000FY2023as of 2023-12-3110-K2024-04-160001493152-24-014822StockholdersEquity
Operating cash flow-$29,485,000FY20232023-01-01 to 2023-12-3110-K2024-04-160001493152-24-014822NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$7.99 per shareFY20232023-01-01 to 2023-12-3110-K2024-04-160001493152-24-014822EarningsPerShareDiluted
Shares outstanding42,633,400 sharesFY2023as of 2024-04-0810-K2024-04-160001493152-24-014822EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2014-2023, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20232023-01-01 to 2023-12-31$13,00010-K2024-04-160001493152-24-014822
RevenueFY20222021-11-01 to 2022-10-31$250,00010-K2023-02-100001493152-23-004167
RevenueFY20212020-11-01 to 2021-10-31$3,240,00010-K2023-02-100001493152-23-004167
RevenueFY20202019-11-01 to 2020-10-31$253,00010-K2022-02-140001493152-22-004469
RevenueFY20192018-11-01 to 2019-10-31$20,884,00010-K2021-01-220001493152-21-001656
RevenueFY20182017-11-01 to 2018-10-31$6,063,00010-K2019-01-110001493152-19-000489
RevenueFY20172016-11-01 to 2017-10-31$12,031,00010-K2019-01-110001493152-19-000489
RevenueFY20162015-11-01 to 2016-10-31$3,994,85610-K2017-12-210001493152-17-014889
RevenueFY20142013-11-01 to 2014-10-31$1,000,00010-K2017-01-090001493152-17-000250
Net incomeFY20232023-01-01 to 2023-12-31-$48,072,00010-K2024-04-160001493152-24-014822
Net incomeFY20222021-11-01 to 2022-10-31-$14,359,00010-K2023-02-100001493152-23-004167
Net incomeFY20212020-11-01 to 2021-10-31-$17,862,00010-K2023-02-100001493152-23-004167
Net incomeFY20202019-11-01 to 2020-10-31-$26,469,00010-K2022-02-140001493152-22-004469
Net incomeFY20192018-11-01 to 2019-10-31-$16,612,00010-K2021-01-220001493152-21-001656
Net incomeFY20182017-11-01 to 2018-10-31-$66,515,00010-K2019-12-200001493152-19-019523
Net incomeFY20172016-11-01 to 2017-10-31-$93,435,00010-K2019-01-110001493152-19-000489
Net incomeFY20162015-11-01 to 2016-10-31-$73,556,23010-K2017-12-210001493152-17-014889
Net incomeFY20152014-11-01 to 2015-10-31-$47,031,11810-K2017-12-210001493152-17-014889
Net incomeFY20142013-11-01 to 2014-10-31-$16,525,31410-K2017-01-090001493152-17-000250
  • Net income for FY2017 was restated: first reported as -$93,435,402 (accession 0001493152-17-014889, filed 2017-12-21).

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-K/A2024-04-262023-12-310001493152-24-016714form10-ka.htm
10-K2024-04-162023-12-310001493152-24-014822form10-k.htm
10-Q2023-11-202023-09-300001493152-23-041998form10-q.htm
10-Q2023-08-102023-06-300001493152-23-027531form10-q.htm
10-Q2023-05-232023-03-310001493152-23-018686form10-q.htm
10-K2023-02-102022-10-310001493152-23-004167form10-k.htm
10-Q2022-09-132022-07-310001493152-22-025666form10-q.htm
10-Q2022-06-082022-04-300001493152-22-016125form10-q.htm
10-Q2022-03-172022-01-310001493152-22-007099form10-q.htm
10-K2022-02-142021-10-310001493152-22-004469form10-k.htm
10-Q2021-09-102021-07-310001493152-21-022350form10-q.htm
10-Q2021-06-142021-04-300001493152-21-014308form10-q.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001100397published by the sourcedata.sec.gov/submissions/CIK0001100397.json2026-10-21
Employer Identification Number (EIN) · US-EIN84-1521955published by the sourcedata.sec.gov/submissions/CIK0001100397.json2026-10-21

Former names

NameFromTo
Advaxis, Inc.2005-01-062023-01-13
GREAT EXPECTATIONS & ASSOCIATES INC1999-12-142005-01-05

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001100397.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001100397.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001100397" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001100397/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001100397/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1100397"}

On SEC EDGAR

About this data